Peter D. Smith
AstraZeneca (Brazil)(BR)
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Chemical Synthesis and Analysis, Catalytic C–H Functionalization Methods, Catalytic Cross-Coupling Reactions
Most-Cited Works
- → Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor(2014)591 cited
- → Asymmetric routes to substituted piperidines(1998)328 cited
- → Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)(2013)258 cited
- → ITER material properties handbook(1996)116 cited
- → Exploiting a fast neutron mutant genetic resource in Pisum sativum (pea) for functional genomics(2013)44 cited
- → Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat(2015)42 cited
- → Catalytic direct amidations in tert -butyl acetate using B(OCH 2 CF 3 ) 3(2019)39 cited
- → Silver-Free Palladium-Catalyzed C(sp3)–H Arylation of Saturated Bicyclic Amine Scaffolds(2017)37 cited
- → Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models(2019)29 cited
- → Novel 4-anilinoquinazolines with C-6 carbon-linked side chains: Synthesis and structure–activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitors(2006)26 cited